New cholesterol-lowering combination pill for at-risk adults
Part of Hormones & metabolism clinical trials.
This study tests a new combination pill containing two cholesterol-lowering medications (laroprovstat and rosuvastatin) in people who have never taken cholesterol medicine before. The goal is to see if the combination works better than either medicine alone at lowering LDL cholesterol, which is the 'bad' cholesterol that can increase heart disease risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have not had a heart attack, stroke, or other major heart/blood vessel event
- Your 10-year risk of developing heart disease is estimated as low based on your health profile
- You have not taken any cholesterol-lowering medication in the past 3 months
- You do not have a history of severe allergic reactions or muscle problems from statin drugs (a common cholesterol medicine)
- Your blood pressure and blood sugar (if diabetic) are well controlled with current treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination pill (laroprovstat plus rosuvastatin) versus rosuvastatin alone to lower LDL cholesterol (the 'bad' cholesterol that builds up in arteries). If you have a history of heart disease or stroke, or are at high risk for one, this trial may help you reduce that risk further.
This trial tests a triple therapy pill (bempedoic acid, ezetimibe, and a high-intensity statin) in patients who have extensive plaque in their heart arteries but have never had a heart attack or stroke. It aims to see if this combination can further lower cholesterol and prevent future problems.
This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.
Hear when a new Hypercholesterolaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.